BRCA2 and breast carcinoma: Survival bias is not likely to be a problem because for 51% of the cases, paraffin-embedded tissue removed at surgery was used for BRCA2-mutation testing, and for most of the remaining women diagnostic blood samples were used, or samples collected shortly after diagnosis in context with research on familial breast cancer during the nineties.